Dynavax to Present at the 2018 Cantor Global Healthcare Conference
September 27 2018 - 4:01PM
Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that
Eddie Gray, Dynavax’s Chief Executive Officer, will present at the
2018 Cantor Global Healthcare Conference on Monday, October 1, 2018
at 10:40 AM ET at the InterContinental New York Barclay Hotel.
The live and replayed versions of the webcast
will be available on the “Events and Presentations” section of the
Dynavax website at
http://investors.dynavax.com/events-presentations.
About DynavaxDynavax is a
fully-integrated biopharmaceutical company focused on leveraging
the power of the body's innate and adaptive immune responses
through toll-like receptor (TLR) stimulation. Dynavax discovers and
develops novel vaccines and immuno-oncology therapeutics. The
Company launched its first commercial product, HEPLISAV-B®
[Hepatitis B Vaccine (Recombinant), Adjuvanted], in January 2018,
following U.S. FDA approval for prevention of infection caused by
all known subtypes of hepatitis B virus in adults age 18 years and
older. Dynavax's lead immunotherapy product, SD-101, is an
investigational cancer immunotherapeutic currently being evaluated
in Phase 1/2 studies and its second cancer immunotherapeutic,
DV281, is in Phase 1 development. For more information, visit
www.dynavax.com.
Contact: Ryan SpencerVP
Corporate Strategy and Communications510.665.4608
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Sep 2023 to Sep 2024